Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study

作者：Thierry André, Kai Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, C.J.A. Punt, Denis Smith, R. Garcia-Carbonero, Julia Alcaide, Peter Gibbs, Christelle de la Fouchardière, F Rivera, Elena Élez, Dung T. Le, Takashi Yoshino, Yu Zuo, D. Fogelman, David E. Adelberg, Luis A. Díaz · 发表于：Annals of Oncology · 年份：2024 · DOI：10.1016/j.annonc.2024.11.012 · 被引用次数：124 · 研究领域：Genetic factors in colorectal cancer、Cancer Immunotherapy and Biomarkers、Colorectal Cancer Treatments and Studies